KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Research & Development (2018 - 2025)

Historic Research & Development for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to $801.0 million.

  • Moderna's Research & Development fell 2955.15% to $801.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year decrease of 2792.62%. This contributed to the annual value of $4.5 billion for FY2024, which is 623.32% down from last year.
  • As of Q3 2025, Moderna's Research & Development stood at $801.0 million, which was down 2955.15% from $700.0 million recorded in Q2 2025.
  • Moderna's Research & Development's 5-year high stood at $1.4 billion during Q4 2023, with a 5-year trough of $401.0 million in Q1 2021.
  • In the last 5 years, Moderna's Research & Development had a median value of $856.0 million in 2025 and averaged $896.4 million.
  • Per our database at Business Quant, Moderna's Research & Development soared by 24869.57% in 2021 and then plummeted by 4266.99% in 2025.
  • Over the past 5 years, Moderna's Research & Development (Quarter) stood at $648.0 million in 2021, then surged by 86.88% to $1.2 billion in 2022, then grew by 16.1% to $1.4 billion in 2023, then decreased by 20.2% to $1.1 billion in 2024, then fell by 28.61% to $801.0 million in 2025.
  • Its Research & Development was $801.0 million in Q3 2025, compared to $700.0 million in Q2 2025 and $856.0 million in Q1 2025.